PTC299
PTC299-VIR-015-COV19
Phase 3 small_molecule terminated
Quick answer
PTC299 for Pneumonia is a Phase 3 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Pneumonia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated